|

Tau2 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Paul S. Aisen1

Indications

  • Preclinical Alzheimer's Disease1
  • Prodromal Alzheimer's Disease1
  • Alzheimer's Disease1
  • Alzheimer Disease1

San Francisco, California1 trial

Alzheimer's Tau Platform: Master Protocol

University of California, San Francisco

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.